Tradewinds Global Investors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-168,457
Closed -$14.1M 92
2016
Q2
$14.1M Sell
168,457
-19,684
-10% -$1.75M 0.91% 40
2016
Q1
$17.3M Buy
188,141
+74,450
+65% +$6.71M 1.04% 39
2015
Q4
$11.5M Buy
113,691
+276
+0.2% +$28.7K 0.68% 56
2015
Q3
$11.1M Buy
113,415
+14,715
+15% +$1.63M 0.55% 62
2015
Q2
$11.6M Buy
98,700
+3,574
+4% +$391K 0.5% 63
2015
Q1
$9.33M Buy
+95,126
New +$9.66M 0.38% 67

Other funds holding GILD

Tradewinds Global Investors's GILD Position: Q3 2016 in Review

Tradewinds Global Investors sold out of Gilead Sciences (GILD) in Q3 2016, closing a stake of 168,457 shares — an estimated $14.1M sold.

Tradewinds Global Investors first reported a position in GILD in Q1 2015 and held it in 6 quarters. The position peaked at $17.3M in Q1 2016. 1,558 funds tracked by Wall St. Rank hold GILD as of Q3 2016.

  • Tradewinds Global Investors reported no remaining Gilead Sciences position as of Q3 2016 after selling out during the quarter.
  • Tradewinds Global Investors sold 168,457 Gilead Sciences shares in Q3 2016, an estimated $14.1M.
  • Tradewinds Global Investors first reported a position in Gilead Sciences in Q1 2015 and held it in 6 quarters.
  • Tradewinds Global Investors's Gilead Sciences position peaked at $17.3M in Q1 2016.
  • 1,558 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2016.

Based on Tradewinds Global Investors's 13F filing for Q3 2016, filed 14 Nov 2016.